Advertisement
Advertisement
U.S. markets close in 3 hours 54 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Quest PharmaTech Inc. (QPTFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.07620.0000 (0.00%)
As of 12:47PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0762
Open0.0762
BidN/A x N/A
AskN/A x N/A
Day's Range0.0762 - 0.0762
52 Week Range0.0513 - 0.0793
Volume50
Avg. Volume252
Market Cap6.209M
Beta (5Y Monthly)1.16
PE Ratio (TTM)N/A
EPS (TTM)-0.3890
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for QPTFF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • QUEST PHARMATECH INC
    Technical Assessment: Bullish in the Intermediate-TermWe are raising our intermediate-term technical outlook to bullish from neutral. The major indices all made a stand at their June lows and posted extremely strong breadth days to open October and the seasonally strong fourth quarter.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • CNW Group

    Quest PharmaTech Announces Sale of Bioceltran Investment and Return of Photodynamic Therapy Technology License

    Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") today announced the sale of its share ownership interest in Bioceltran Co., Ltd. ("Bioceltran") to Dr. Sang Ho Jang, founder of Bioceltran, for sale proceeds of $300,0000 and the termination and return of the Photodynamic Therapy ("PDT") technology license. Bioceltran is a private, Korea based company developing skin penetrating active molecules for cosmetic and pharmaceutical use.

  • CNW Group

    Quest PharmaTech Announces Results from AGM

    Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") today announced the results of its July 19, 2022 annual general meeting of shareholders.

  • CNW Group

    Quest PharmaTech Provides Corporate Update

    Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that it has borrowed $1 million of working capital funding from one of its investee companies, OncoQuest Inc.

Advertisement
Advertisement